Alto Neuroscience (ANRO) Depreciation & Amortization (CF) (2023 - 2026)

Alto Neuroscience has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $184000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $184000.0, down 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $680000.0 (down 2.86% YoY), and the FY2025 annual result was $700000.0, up 40.0% from the prior year.
• Depreciation & Amortization (CF) came in at $184000.0 for Q1 2026 at Alto Neuroscience, down from $196000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $200000.0 in Q3 2024 to a low of $86000.0 in Q1 2023.
• The 4-year median for Depreciation & Amortization (CF) is $100000.0 (2023), against an average of $143307.7.
• Across the five-year window, Depreciation & Amortization (CF) soared 106.19% in 2025 and decreased 8.0% in 2026, its largest moves.
• Alto Neuroscience's Depreciation & Amortization (CF) stood at $100000.0 in 2023, then soared by 100.0% to $200000.0 in 2024, then retreated by 2.0% to $196000.0 in 2025, then retreated by 6.12% to $184000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $184000.0 (Q1 2026), $196000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.